Ardron M, Macfarlane I A, Martin P, Walton C, Day J, Robinson C, Calverly P
Diabetic Clinic, Walton Hospital, Liverpool, United Kingdom.
J Diabet Complications. 1989 Jul-Sep;3(3):154-7. doi: 10.1016/0891-6632(89)90038-x.
Smoking may be a risk factor for the development of diabetic nephropathy. Therefore, the urinary excretion of albumin, alpha-1-microglobulin, and N-acetyl-BD glucosaminidase was studied in 24 young adult diabetic patients who smoked. None of these patients had urine samples positive for albumin as determined by the Albustix method (i.e., a urinary concentration of albumin of less than 0.5 g in 24 hr). Control groups were nonsmoking diabetic patients (matched for age and duration of diabetes) and nondiabetic subjects (smokers and nonsmokers). Expired breath carbon monoxide and the urinary nicotine metabolite cotinine were measured as objective markers of smoking load. No significant differences in concentrations of urinary proteins were found among any of the four groups. Therefore, smoking is not associated with the development of an increased urinary excretion of albumin within the "microalbuminuria" range. However, further studies are required to determine whether smoking is a risk factor for the progression of established microalbuminuria to Albustix positive proteinuria in diabetic patients.
吸烟可能是糖尿病肾病发生的一个风险因素。因此,对24名吸烟的年轻成年糖尿病患者的白蛋白、α-1-微球蛋白和N-乙酰-β-D-氨基葡萄糖苷酶的尿排泄情况进行了研究。根据Albustix法测定,这些患者中没有一人的尿样白蛋白呈阳性(即24小时尿白蛋白浓度低于0.5克)。对照组为非吸烟糖尿病患者(年龄和糖尿病病程匹配)以及非糖尿病受试者(吸烟者和非吸烟者)。测量呼出气体中的一氧化碳和尿中尼古丁代谢产物可替宁,作为吸烟量的客观指标。四组中任何一组的尿蛋白浓度均未发现显著差异。因此,在“微量白蛋白尿”范围内,吸烟与尿白蛋白排泄增加的发生无关。然而,需要进一步研究以确定吸烟是否是糖尿病患者已确诊的微量白蛋白尿进展为Albustix阳性蛋白尿的风险因素。